Dysregulation of locus coeruleus development in congenital central hypoventilation syndrome
- PMID: 25975378
- PMCID: PMC4503865
- DOI: 10.1007/s00401-015-1441-0
Dysregulation of locus coeruleus development in congenital central hypoventilation syndrome
Abstract
Human congenital central hypoventilation syndrome (CCHS), resulting from mutations in transcription factor PHOX2B, manifests with impaired responses to hypoxemia and hypercapnia especially during sleep. To identify brainstem structures developmentally affected in CCHS, we analyzed two postmortem neonatal-lethal cases with confirmed polyalanine repeat expansion (PARM) or Non-PARM (PHOX2B∆8) mutation of PHOX2B. Both human cases showed neuronal losses within the locus coeruleus (LC), which is important for central noradrenergic signaling. Using a conditionally active transgenic mouse model of the PHOX2B∆8 mutation, we found that early embryonic expression (<E10.5) caused failure of LC neuronal specification and perinatal respiratory lethality. In contrast, later onset (E11.5) of PHOX2B∆8 expression was not deleterious to LC development and perinatal respiratory lethality was rescued, despite failure of chemosensor retrotrapezoid nucleus formation. Our findings indicate that early-onset mutant PHOX2B expression inhibits LC neuronal development in CCHS. They further suggest that such mutations result in dysregulation of central noradrenergic signaling, and therefore, potential for early pharmacologic intervention in humans with CCHS.
Figures






References
-
- Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneau M, et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet. 2003;33:459–461. doi: 10.1038/ng1130. - DOI - PubMed
-
- Antic NA, Malow BA, Lange N, McEvoy RD, Olson AL, Turkington P, Windisch W, Samuels M, Stevens CA, Berry-Kravis EM, et al. PHOX2B mutation-confirmed congenital central hypoventilation syndrome: presentation in adulthood. Am J Respir Crit Care Med. 2006;174:923–927. doi: 10.1164/rccm.200605-607CR. - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- UL1 TR001070/TR/NCATS NIH HHS/United States
- 8UL1TR000090-05/TR/NCATS NIH HHS/United States
- U01 HL098179/HL/NHLBI NIH HHS/United States
- HL098179/HL/NHLBI NIH HHS/United States
- UL1 TR000090/TR/NCATS NIH HHS/United States
- P01 NS083513/NS/NINDS NIH HHS/United States
- HL089742/HL/NHLBI NIH HHS/United States
- R01 HL089742/HL/NHLBI NIH HHS/United States
- UM1 HL098179/HL/NHLBI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 HL100406/HL/NHLBI NIH HHS/United States
- R01 HL108677/HL/NHLBI NIH HHS/United States
- K26 OD010927/OD/NIH HHS/United States
- Howard Hughes Medical Institute/United States
- UL1RR024131/RR/NCRR NIH HHS/United States
- HL108677/HL/NHLBI NIH HHS/United States
- HL100406/HL/NHLBI NIH HHS/United States
- NS083513/NS/NINDS NIH HHS/United States
- OD010927/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources